Animal & Plant Derived Vaccines

It has been about 30 years since the first plant engineering technology was established. Although the concept of plant-based pharmaceuticals or vaccines motivates us to develop practicable commercial products using plant engineering, there are some difficulties in reaching the final goal: to manufacture an approved product. At present, the only plant-made vaccine approved by the United States Department of Agriculture is a Newcastle disease vaccine for poultry that is produced in suspension-cultured tobacco cells. The progress toward commercialization of plant-based vaccines takes much effort and time, but several candidate vaccines for use in humans and animals are in clinical trials. This review discusses plant engineering technologies and regulations 

    Related Conference of Animal & Plant Derived Vaccines

    October 25-26, 2019

    37thVaccination, Immunization & Antibiotics

    Vancouver, Canada
    November 12-13, 2019

    35th World Vaccines & Immunization Congress

    Brisbane, Australia

    Animal & Plant Derived Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in